
WHOCCLeish
@whoccl
Our laboratory is a WHO Collaborating Centre for Leishmaniasis since 1997, supporting WHO strategy for the control, research and training in leishmaniasis
ID: 1009711825888391168
21-06-2018 08:17:13
915 Tweet
464 Followers
141 Following


We're thrilled to announce that we've been awarded the NSERC / CRSNG Discovery Grant for our project, LEISH-INSIGHT: Decoding AMR and fitness compensatory mechanisms in protozoan parasites of the genus Leishmania. Excited to dive into this research!🔬 #Leishmania #AMR Université de Montréal



Fantastic talk by Rubens do Monte at the #CPN2024 conference in #Banff #Diagnostics #Leishmania #pointOfCare


I'm happy to announce that I have been nominated as a member of the Canadian Network for Neglected Tropical Diseases Steering Committee. I'll do my best to contribute to the benefit of patients affected by NTDs around the world. Canadian Network for Neglected Tropical Diseases

Leishmaniasis en Europa: un desafío emergente para el que no estamos preparados theconversation.com/leishmaniasis-… vía The Conversation ES un placer colaborar con #JavierMoreno WHOCCLeish ! #Leishmania Canadian Network for Neglected Tropical Diseases

#Leishmaniasis es un problema creciente de #saludpública en Europa. Lo explicamos en este artículo escrito en colaboración con Christopher Fernandez-Prada (He/Him). Université de Montréal Canadian Network for Neglected Tropical Diseases Neglected Global Diseases Initiative at UBC Instituto de Salud Carlos III (ISCIII) Ministerio de Sanidad CIBERINFEC SEMTSI WHO/Europe theconversation.com/leishmaniasis-… vía The Conversation ES


Queremos anunciaros la próxima conferencia del Dr. Javier Moreno en la Fac. Med. Veterinaria Université de Montréal, organizada por GREZOSP Martes, 2 de julio, 12:00 h. (Montreal) 18:00 h (Madrid) umontreal.zoom.us/j/83230708030?… Christopher Fernandez-Prada (He/Him) Instituto de Salud Carlos III (ISCIII) CIBERINFEC SEMTSI Grupo Leishmania



Today we are delighted to welcome our colleagues from the Skin NTD LabNet to our laboratory WHOCCLeish at the National Center for Microbiology Instituto de Salud Carlos III (ISCIII) CIBERINFEC Ricet leish.spain SEMTSI WHO/Europe Grupo Leishmania


A clinical trial in Sudan by Drugs for Neglected Diseases initiative & University of Khartoum has found a shorter, safer, & more effective treatment against post-kala-azar dermal leishmaniasis (PKDL). It reduces hospital stays by over 50% and improves cure rates. Read more ⬇️bit.ly/4cOpWYD #beatNTDs

Take a look at our new article ! Instituto de Salud Carlos III (ISCIII) DNDi_Español Drugs for Neglected Diseases initiative CIBERINFEC Ricet leish.spain SEMTSI NTDs SEMTSI Grupo Leishmania WHO African Region WHO/Europe @BU_LabNet httpsapphiree://link.springer.com/10.1007/s44197-024-00270-0

Take a look at our new article ! Instituto de Salud Carlos III (ISCIII) DNDi_Español Drugs for Neglected Diseases initiative CIBERINFEC Ricet leish.spain SEMTSI NTDs SEMTSI Grupo Leishmania WHO African Region WHO/Europe @BU_LabNet link.springer.com/10.1007/s44197…



We received in the lab Francesco Dondi Università di Bologna and Girma S Abadura Armauer Hansen They have come to characterize clinical #Leishmania strains isolated in internacional projects in which we are collaborating Instituto de Salud Carlos III (ISCIII) CIBERINFEC SEMTSI Grupo Leishmania Drugs for Neglected Diseases initiative leish.spain

